跳至主要内容
临床试验/EUCTR2004-000592-33-IE
EUCTR2004-000592-33-IE进行中(未招募)不适用

Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF Study

Gentium S.p.A0 个研究点目标入组 290 人开始时间: 2006年1月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
290

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients < 18 years who have myeloablative conditioning and at least one of the following risk factors:
  • Children having a second myeloablative stem cell transplant
  • Allogeneic stem cell transplants for leukaemia >2 relapses
  • Liver disease
  • History of treatment with gemtuzumab ozogamicin (Mylotarg)
  • Conditioning with busulfan and melphalan
  • Osteopetrosis
  • Macrophage activating syndromes
  • Adrenoleukodystrophy
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Those who do not fulfill the inclusion criteria.
  • Patients who are pregnant.

研究者

发起方
Gentium S.p.A

相似试验

进行中(未招募)
1 期
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1 Level: LLT Classification code 10047217 Term: Venoocclusive syndrome of the liverMedDRA version: 9.1 Level: LLT Classification code 10047207 Term: Veno-occlusive liver damage
EUCTR2004-000592-33-GBGentium S.p.A270
进行中(未招募)
不适用
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1Level: LLTClassification code 10047217Term: Venoocclusive syndrome of the liverMedDRA version: 9.1Level: LLTClassification code 10047207Term: Veno-occlusive liver damage
EUCTR2004-000592-33-SEGentium S.p.A270
进行中(未招募)
不适用
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1Level: LLTClassification code 10047217Term: Venoocclusive syndrome of the liverMedDRA version: 9.1Level: LLTClassification code 10047207Term: Veno-occlusive liver damage
EUCTR2004-000592-33-CZGentium S.p.A270
进行中(未招募)
不适用
Prospective study of the incidence and outcome of Veno-occlusive disease (VOD)with the prophylactic use of Defibrotide (DF, Gentium, Italy) in pediatric stem cell transplantatioPrevention of hepatic veno-occlusive disease in pediatric patients at high risk of VODMedDRA version: 14.1Level: PTClassification code 10047216Term: Venoocclusive liver diseaseSystem Organ Class: 10019805 - Hepatobiliary disorders
EUCTR2004-000592-33-ITGENTIUM360
尚未招募
Unknown
Incidence of catheter colonization in Regional Anaesthesia.
CTRI/2024/05/067327Fluid research Grant Christian Medical College Vellore